Rigel Pharmaceuticals Inc Cash Flow Reinvestment Rate
Rigel Pharmaceuticals Inc cash flow reinvestment rate. Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Reinvestment Rate of 2.86x as of June 2026, reinvesting $87.80 Million (capex $0.00 plus investments $87.80 Million) from operating cash flow of $30.65 Million. Explore Rigel Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Rigel Pharmaceuticals Inc (2010–2025)
Cash flow reinvestment rate of Rigel Pharmaceuticals Inc from 2010 to 2025. Historical reinvestment intensity for Rigel Pharmaceuticals Inc across 4 annual periods. Explore reinvestment intensity of Rigel Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Rigel Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2010–2025)
Rigel Pharmaceuticals Inc cash flow reinvestment rate by year from 2010 to 2025. Year-by-year capital reinvestment analysis for Rigel Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does Rigel Pharmaceuticals Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.22x | $92.36 Million | $75.66 Million | $0.00 | ▲ +748.9% |
| 2024 | 0.14x | $4.53 Million | $31.47 Million | $396.00K | ▼ -98.9% |
| 2021 | 13.62x | $80.04 Million | $5.88 Million | $627.00K | ▲ +17778.1% |
| 2010 | 0.08x | $3.56 Million | $46.74 Million | $3.56 Million | — |